Factor Xa inhibition by rivaroxaban attenuates cardiac remodeling due to intermittent hypoxia

MLA

Shota Tanikawa, et al. “Factor Xa Inhibition by Rivaroxaban Attenuates Cardiac Remodeling Due to Intermittent Hypoxia.” Journal of Pharmacological Sciences, vol. 137, July 2018, pp. 274–82. EBSCOhost, https://doi.org/10.1016/j.jphs.2018.07.002.

APA

Shota Tanikawa, Takehiro Yamaguchi, Yoshio Ijiri, Hideki Imano, Ryuji Kato, Yasukatsu Izumi, Minoru Yoshiyama, Atsuo Nomura, Tetsuya Hayashi, & Fumi Yoshimura. (2018). Factor Xa inhibition by rivaroxaban attenuates cardiac remodeling due to intermittent hypoxia. Journal of Pharmacological Sciences, 137, 274–282. https://doi.org/10.1016/j.jphs.2018.07.002

Chicago

Shota Tanikawa, Takehiro Yamaguchi, Yoshio Ijiri, Hideki Imano, Ryuji Kato, Yasukatsu Izumi, Minoru Yoshiyama, Atsuo Nomura, Tetsuya Hayashi, and Fumi Yoshimura. 2018. “Factor Xa Inhibition by Rivaroxaban Attenuates Cardiac Remodeling Due to Intermittent Hypoxia.” Journal of Pharmacological Sciences 137 (July): 274–82. doi:10.1016/j.jphs.2018.07.002.